Lombardi Cancer Center, Georgetown University Medical Center — Washington D.C., District of Columbia

Lombardi Cancer Center, Georgetown University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Cancer Center, Georgetown University Medical Center has participated in 3 clinical trials.

Therapeutic areas: Multiple Myeloma, Pancreatic Cancer.

Sponsors: Millennium Pharmaceuticals, Inc., INSYS Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Cancer Center, Georgetown University Medical Center?

Lombardi Cancer Center, Georgetown University Medical Center has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Cancer Center, Georgetown University Medical Center conducted?

Lombardi Cancer Center, Georgetown University Medical Center has 3 clinical trials on record. Their work covers Multiple Myeloma, Pancreatic Cancer.

Is Lombardi Cancer Center, Georgetown University Medical Center accredited by Crixeo Health?

Lombardi Cancer Center, Georgetown University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Cancer Center, Georgetown University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.